Challenge and promise: The role of miRNA for pathogenesis and progression of malignant melanoma

Clinical Epigenetics

Volumn 1, Issue 1-2, 2010, Pages 7-11

  Essa, Salma ^a   Denzer, N ^a   Mahlknecht, U ^a   Klein, R ^b   Collnot, E M ^c   Reichrath, J ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SEQ IT GmbH amp Co KG   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Cancer; Human cancer metastasis; Malignant melanoma; MicroRNA

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 PHENYLBUTYRIC ACID; 5 AZA 2' DEOXYCYTIDINE; ANTISENSE OLIGONUCLEOTIDE; GEMCITABINE; LET 7A 3; MESSENGER RNA; MICRORNA; MICRORNA 10B; MICRORNA 124A; MICRORNA 124A3; MICRORNA 126; MICRORNA 127; MICRORNA 141; MICRORNA 147; MICRORNA 152; MICRORNA 192; MICRORNA 21; MICRORNA 335; MICRORNA 373; MICRORNA 529C; MICRORNA 9 1; RNA; RNA POLYMERASE II; TOPOTECAN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; DNA METHYLATION; DRUG MECHANISM; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; LIPOSOMAL GENE DELIVERY SYSTEM; MELANOMA; MELANOMA CELL; METASTASIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA DEGRADATION; RNA SEQUENCE; RNA SYNTHESIS; TRANSLATION REGULATION; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM;

EID: 79952362285     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-010-0001-7     Document Type: Article

References (31)

1. Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297
2. Blower PE, Verducci JS, Lin S (2007) MicroRNA expression profiles for the NCI-60cancer cell panel. Mol Cancer Ther 6:1483-1491 (Pubitemid 46954015)
3. Eigentler TK, Caroli UM, Radny P, Garbe C (2003) Palliative therapy of disseminated malignant melanoma: A systematic review of 41 randomised clinical trials. Lancet Oncol 4:748-759 (Pubitemid 37527210)
4. Grabacka M, Plonka PM, Urbanska K, Reiss K (2006) Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res 12:3028-3036 (Pubitemid 43837347)
5. Halaban R, Krauthammer M, Pelizzola M, Cheng E, Kovacs D, Sznol M (2009) Integrative analysis of epigenetic modulation in melanoma cell resoponse to decitabine: Clinical implications. PLoS ONE 4:e4563
6. Hammond SM (2006) MicroRNA therapeutics: A new niche for antisense nucleic acids. Trends Mol Med 12:99-101
7. Horwich MD, Ph Zamore D (2008) Design and delivery of antisense oligonucleotides to block microRNA function in cultured drosophila and human cells. Nat Protoc 3:1537-1549
8. Igoucheva O, Alexeev V (2009) MicroRNA-dependent regulation of cKit in cutaneous melanoma. Biochem Biophys Res Commun 379:790-794
9. Kurihara Y, Watanabe Y (2004) Arabidopsis micro-RNA biogenesis through Dicer-like 1 protein functions. Proc Natl Acad Sci USA 101:12753-12758 (Pubitemid 39122095)
10. Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F, Kreipe H (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214:17-24
11. Liu Z, Sall A, Yang D (2008) MicroRNA: An emerging therapeutic target and intervention tool. Int J Mol Sci 9:978-999 (Pubitemid 351948835)
12. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20 (Pubitemid 40094598)
13. Lujambio A, Calin GA, Villanueva A, Ropero S, Céspedes MS, Blanco D et al (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105:13556-13561
14. Ma L, Feldstein JT, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682-688 (Pubitemid 47552092)
15. Ma Z, Lui WO, Fire A, Dadras SS (2009) Profiling and discovery of novel miRNAs from formalin-fixed, paraffin-embedded melanoma and nodal specimens. J Mol Diagn 11:420-429
16. Meng F, Henson R, Lang M (2006) Involvement of micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-2129 (Pubitemid 43816961)
17. Molnára V, Tamásia V, Bakosa B, Wienera Z, Falus A (2008) Changes in miRNA expression in solid tumors: An miRNA profiling in melanomas. Semin Cancer Biol 18:111-122
18. Mueller DW, Rehli M, Bosserhoff AK (2009) miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Investig Dermatol 129:1740-1751
19. Negrini M, Adrian Calin GA (2008) Breast cancer metastasis: A microRNA story. Breast Cancer Res 10:203
20. Rigel DS, Carucci JA (2000) Malignant melanoma: Prevention, early detection, and treatment in the 21st century. Cancer J Clin 50:215-236, quiz 237-40 (Pubitemid 30654880)
21. Rothhammer T, Bosserhoff AK (2007) Epigenetic events in malignant melanoma. Pigment Cell Res 20:92-111 (Pubitemid 46439524)
22. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G (2009) Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Molec Cell Biol Res Commun 379:726-731
23. Saito Y, Liang G, Egger G (2006) Specific activation of microRNA- 127 with downregulation of the proto to-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9:435-443 (Pubitemid 43832188)
24. Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A et al (2009) MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer 9999:page NA
25. Seike M (2009) MicroRNA expression profiles in lung cancer cooperated with drug sensitivity to EGFR tyrosine kinase inhibitor. J Nippon Med Sch 76:275-276
26. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY (2006) miR-21-mediated tumor growth. Oncogene Epub 26:2799-2803 (Pubitemid 46663837)
27. Suárez Y, Sessa WC (2009) MicroRNAs as novel regulators of angiogenesis. Circ Res 104:442-454
28. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R (2006) A genetic screen implicates miR-372 and miR-373 as oncogenes in testicular germ cell tumors. Cell 124:1169-1181
29. Wurdinger T, Costa FF (2006) Molecular therapy in the microRNA era. Pharmacogenomic J 7:297-304 (Pubitemid 47471308)
30. Zhang L, Huang J, Yang N, Greshock J (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Natl Acad Sci USA 9136-9141 (Pubitemid 43902545)
31. Zhang W, Dahlberg JE, Tam W (2007) MicroRNAs in tumorigenesis. Am J Pathol 171:728-738